People · Operator
Named in public records as an officer, director or promoter · active 2018–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Steep Hill, Inc. | — | Biotechnology | Series A | $10.1M | $144.6M | 2018 |
Stephen Finfer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Finfer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mitchell Baruchowitz | 1 | 8 |
| David Lampach | 1 | 2 |
| Nigel Stobart | 1 | 2 |
| Mitchell Kulick | 1 | 2 |
| Stephen DeAngelo | 1 | 2 |
| Jmichaele Keller | 1 | 1 |
| Addison Demoura | 1 | 1 |
| Andrew Rosenstein | 1 | 1 |
| Jeffrey Monat | 1 | 1 |
| Brett Finkelstein | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.